Liberal Transfusion Strategy in AMI May Reduce Composite Outcome of Death & Myocardial Infarction
The following is a summary of “Liberal versus restrictive transfusion strategies in acute...
Read MoreOct 3, 2024
The following is a summary of “Liberal versus restrictive transfusion strategies in acute...
Read MoreOct 2, 2024
1. In this secondary analysis of the MINT trial, 30-day risks for the composite outcome of death...
Read MoreSep 19, 2024
WEDNESDAY, Sept. 18, 2024 (HealthDay News) — The prevalence of acute myocardial infarction...
Read MoreSep 13, 2024
The following is a summary of “Healthcare Resource Utilization Following Acute Myocardial...
Read MoreSep 10, 2024
Click here to read this study in NEJM. ©2024 2 Minute Medicine, Inc. All rights reserved. No...
Read MoreSep 5, 2024
WEDNESDAY, Sept 4, 2024 (HealthDay News) — Young patients with myocardial infarction (MI)...
Read MoreSep 2, 2024
Complete revascularization is the standard treatment for patients with ST-segment elevation myocardial infarction (STEMI) and multivessel disease. The Functional Assessment in Elderly MI Patients with Multivessel Disease (FIRE)...
Read MoreAug 16, 2024
1. Sulfonylurea, insulin therapy, and metformin resulted in a significant relative risk reduction...
Read MoreAug 13, 2024
This course discusses a study that sought to identify self-experienced triggers of MI and...
Read MoreJul 15, 2024
Specific alterations in gut microbiota and metabolites have been linked to AMI, with CBLB potentially playing an essential role. However, the precise interactions remain understudied, creating a significant gap in our...
Read MoreJul 6, 2024
The following is a summary of “Invasive mechanical ventilation in cardiogenic shock complicating...
Read MoreJun 17, 2024
The Stress Hyperglycemia Ratio (SHR) potently predicts adverse outcomes in patients with cardiovascular and cerebrovascular diseases. However, the relationship between SHR and short-term mortality risk in patients with a first...
Read MoreJun 10, 2024
Acute myocardial infarction (AMI) is a serious condition that occurs when part of the heart is subjected to ischemia episodes, following partial or complete occlusion of the epicardial coronary arteries. The resulting damage to...
Read MoreJun 8, 2024
1. In this randomized controlled trial, compared to culprit-lesion-only percutaneous coronary...
Read MoreJun 7, 2024
1. In this randomized controlled trial, empagliflozin was not shown to decrease the risk of...
Read MoreMay 8, 2024
Click here to read this study in NEJM. ©2024 2 Minute Medicine, Inc. All rights reserved. No works...
Read MoreMay 7, 2024
Click to read the study in NEJM ©2024 2 Minute Medicine, Inc. All rights reserved. No works may be...
Read MoreApr 26, 2024
Click here to read this study in NEJM. ©2024 2 Minute Medicine, Inc. All rights reserved. No...
Read MoreApr 25, 2024
1. In this randomized controlled trial, long-term beta-blockers did not impact all-cause mortality...
Read MoreApr 10, 2024
1. Intravascular imaging-guided PCI significantly reduces target lesion failure compared to...
Read MoreSed vitae nulla id ipsum molestie scelerisque vitae vitae ligula. Fusce a massa tortor.
Insights from the leaders in medical research, trending topics in clinical medicine, and perspectives from your colleagues.
Subscribe to our free Newsletters to receive weekly emails, and even get a laugh or two from our medical cartoons.